fda tirzepatide shortage resolved october 2 2024 says years-long is resolved, will give limited leeway to compounders Zepbound, Mounjaro shortages are resolved,

A systematic approach to medication management protects both the therapeutic investment and treatment outcomes

The group lawsuit representing people harmed by Mounjaro and other GLP-1 drugs has grown by 486 cases between August and September of 2025

Meal prep strategy: the Sunday system Meal prepping on tirzepatide is not about being organized for fun

This dual-receptor mechanism is why tirzepatide often produces greater weight loss in clinical trialspatients experience suppression across multiple metabolic checkpoints rather than one

Yes if you experience significant weight regain after stopping tirzepatide and still meet the clinical criteria for treatment, restarting is generally an option

PlexusDx tirzepatide is compounded in licensed 503A pharmacies under FDA quality oversight, though compounded medications are not FDA-approved like branded versions